Literature DB >> 22040451

Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans.

Y Matsumoto1, S Miyazaki, D H Fukunaga, K Shimizu, S Kawamoto, K Sekimizu.   

Abstract

AIMS: To develop an in vivo system that could quantitatively evaluate the therapeutic effects of antifungal drugs using a silkworm infection model with Cryptococcus neoformans. METHODS AND
RESULTS: Silkworms reared at 37°C died after an injection of viable serotype A C. neoformans fungus into the haemolymph. The serotype A C. neoformans, which is known to have higher mammal pathogenicity than the serotype D, was also more virulent against the silkworm. Furthermore, the deletion mutants of genes gpa1, pka1 and cna1, which are genes known to be necessary for the pathogenesis in mammals, showed an increase in the number of fungal cells necessary to kill half of the silkworm population (LD(50) value). Antifungal drugs, amphotericin B, flucytosine, fluconazole and ketoconazole, showed therapeutic effects in silkworms infected with C. neoformans. However, amphotericin B was not therapeutically effective when injected into the silkworm intestine, comparable to the fact that amphotericin B is not absorbed by the intestine in mammals.
CONCLUSIONS: The silkworm-C. neoformans infection model is useful for evaluating the therapeutic effects of antifungal drugs. SIGNIFICANCE AND IMPACT OF THE STUDY: The silkworm infection model has various advantages for screening antifungal drug candidates. We can also elucidate the cryptococcal pathogenesis and evaluate the in vivo pharmacokinetics and toxicity of each drug.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040451     DOI: 10.1111/j.1365-2672.2011.05186.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  20 in total

1.  Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.

Authors:  Fumiaki Tabuchi; Yasuhiko Matsumoto; Masaki Ishii; Keita Tatsuno; Mitsuhiro Okazaki; Tomoaki Sato; Kyoji Moriya; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2017-02-15       Impact factor: 2.649

2.  D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus.

Authors:  Fumiaki Tabuchi; Yasuhiko Matsumoto; Masaki Ishii; Keita Tatsuno; Mitsuhiro Okazaki; Tomoaki Sato; Kyoji Moriya; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2017-06-07       Impact factor: 2.649

3.  Fluorescence imaging for a noninvasive in vivo toxicity-test using a transgenic silkworm expressing green fluorescent protein.

Authors:  Yoshinori Inagaki; Yasuhiko Matsumoto; Masaki Ishii; Keiro Uchino; Hideki Sezutsu; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

4.  Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes.

Authors:  Yasuhiko Matsumoto; Masaki Ishii; Yohei Hayashi; Shinya Miyazaki; Takuya Sugita; Eriko Sumiya; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

5.  Metabonomic analysis of Bombyx mori (Heterocera: Bombysidae) treated with acetaminophen.

Authors:  W M Yin; X Xu; Y He; G B Wei; Y H Sima; Xu Shi-Qing
Journal:  J Insect Sci       Date:  2014-01-01       Impact factor: 1.857

6.  An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis.

Authors:  Masaki Ishii; Yasuhiko Matsumoto; Tsuyoshi Yamada; Shigeru Abe; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

Review 7.  Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents.

Authors:  Suresh Panthee; Atmika Paudel; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  Front Microbiol       Date:  2017-03-07       Impact factor: 5.640

8.  Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymph.

Authors:  Yoshinori Inagaki; Yasuhiko Matsumoto; Keiko Kataoka; Naoya Matsuhashi; Kazuhisa Sekimizu
Journal:  BMC Pharmacol Toxicol       Date:  2012-11-08       Impact factor: 2.483

9.  An in vivo invertebrate evaluation system for identifying substances that suppress sucrose-induced postprandial hyperglycemia.

Authors:  Yasuhiko Matsumoto; Masaki Ishii; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

Review 10.  Silkworm: A Promising Model Organism in Life Science.

Authors:  Xu Meng; Feifei Zhu; Keping Chen
Journal:  J Insect Sci       Date:  2017-09-01       Impact factor: 1.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.